BioSpace News Archive

Visus Therapeutics Inc. today announced the appointment of Eric D. Donnenfeld, M.D., to the Company’s Board of Directors.

Meihua International Medical Technologies Co., Ltd. (“MHUA” or the “Company”) (NASDAQ: MHUA) today announced the Company’s subsidiary Jiangsu Huadong Medical Device Industrial Co., Ltd (“Jiangsu Huadong”) has entered into a strategic cooperation agreement (the “Cooperation Agreement”) with Getein Biotech Inc.

Zynerba Pharmaceuticals, Inc. today announces the publication of a paper entitled, “Role of the Endocannabinoid System in Fragile X Syndrome: Potential Mechanisms for Benefit From Cannabidiol Treatment,” in the Journal of Neurodevelopmental Disorders. The review of evidence suggests a central role for the endocannabinoid sys

Citius Pharmaceuticals, Inc. today announced that Chairman and CEO Leonard Mazur will present at the Sidoti Micro-Cap Virtual Conference on January 18, 2023.

Takeda (TSE:4502/NYSE:TAK) today announced that EXKIVITY® (mobocertinib) has been approved by the National Medical Products Administration (NMPA) of China for the treatment of adult patients with locally advanced or metastatic non-small cell lung cancer.

Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products, today announced preliminary unaudited fourth quarter and full year 2022 revenue.

Paige announced a collaboration with Microsoft to apply the power of artificial intelligence (AI) to digital pathology images to develop and deliver a new generation of clinical applications and computational biomarkers to transform cancer diagnosis and patient care.

Rosalind Franklin University of Medicine and Science structural biologist Min Lu, PhD, was recently awarded a four-year, $1.3 million grant from the National Institutes of General Medical Sciences to investigate new therapeutic strategies to combat multidrug resistance.

Leading technology consultancy for the healthcare industry hires experienced health IT executive to lead its sales operations

Eurofins CDMO Alphora Inc. is pleased to announce the relocation and expansion of its API development laboratories from 2395 Speakman Drive to its new, owned facility at 2070 Hadwen Road, located within the Sheridan Research Park in Mississauga, Ontario, Canada.